Since health insurance is tied to employment in the United States, Americans are losing their insurance just as they need it most. We asked economist Fiona Scott Morton, an expert on the healthcare industry, what a better system would look like.
The story of EHRs serves as a prelude to what we’re experiencing today in almost every facet of our lives: a utopian promise of ubiquitous data tempered by technical challenges and concerns over privacy.
After patients are treated at in-network hospitals, they often receive large, unexpected bills from out-of-network doctors. A new study finds that out-of-network charges from anesthesiologists, pathologists, radiologists, and assistant surgeons increase spending by $40 billion annually.
A new study led by Yale SOM’s Arthur J. Swersey, using decision analysis techniques, finds that increasing the number of biopsy needles and using probability modeling to analyze the results can help prevent unnecessary treatment while identifying dangerous cancers.
This month, the Trump administration announced a series of steps to overhaul the kidney transplant system. We asked operations expert Vahideh Manshadi if the changes could make a difference for patients.
A recent lawsuit alleged that a billionaire investor bought the rights to a new drug just to eliminate a potential competitor. We asked Yale SOM's Florian Ederer to explain why a "catch-and-kill" merger can be damaging and what to do about the phenomenon.